The Abiding "Fertility Myth"
By Gina Maranto, Biopolitical Times guest contributor
| 11. 09. 2011
Since at least the mid-1990s, the popular press in the developed world has been spreading the word that women’s ability to get pregnant declines with age. I wrote an Atlantic Magazine cover article on the implications of delayed childbearing in 1995, and the biological facts haven’t exactly changed over the ensuing 16 years.
It’s true that IVF success rates among older women have increased due to
the use of donor eggs. Too, egg freezing has become more viable due to
the advent of the high-speed cooling process known as vitrification [PDF]. That technique has led to a whole mini-industry in egg banking, a.k.a. elective oocyte cryopreservation, but success rates continue to be quite low [PDF, registration required], so the procedure doesn’t significantly alter the situation despite claims to the contrary. One recent meta-analysis suggested that those women who have opted to freeze their eggs might have done so too late to make a real difference.
So I was surprised to discover, checking up on recent literature, that unrealistic views about women’s fertility continue to be quite common among college...
Related Articles
Not the species, certainly, but the Institute of that name, which was founded by transhumanist philosopher Nick Bostrom in 2005 as a research group at Oxford University. According to a recently posted Final Report, its goal was “to pursue the big questions in a transdisciplinary way” by pulling together “researchers from disciplines such as philosophy, computer science, mathematics, and economics.” This evolved before long into the study and promotion of “effective altruism” and “longtermism” as...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...